Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Clinical trial NCT03383094 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03383094
- Sponsor
- Loren Mell, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2026-12-31
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.